Browse the evidence

In patients with type 2 diabetes mellitus, higher body weight variability (fluctuation) is associated with a significantly increased risk of cardiovascular events and mortality, independent of mean body weight and traditional risk factors.

If you have type 2 diabetes, avoiding large swings in your body weight is just as important for your heart health as maintaining a healthy average weight. Try to maintain consistent lifestyle habits rather than cycling through intense diets and regain, as this variability is linked to higher risks of heart attacks and stroke.

Pharmacotherapy and bariatric surgery are more intensive interventions that should be reserved for individuals with greater health risk due to obesity-related complications or those who struggle to lose weight with lifestyle management alone.

If you have a BMI over 30 (or 27 with health issues) and lifestyle changes aren't enough, discuss medications or surgery with your doctor. These are more intensive options with higher potential weight loss (5-15% for drugs) but also higher risks, so they are best for those with significant health complications.

Resistance exercise increases the turnover (synthesis and degradation) of individual muscle proteins without necessarily increasing net protein abundance or synthesis rates, particularly when performed under a high-fat, low-carbohydrate diet.

If you are doing resistance training, expect your muscles to remodel by breaking down and rebuilding proteins, even if you don't see immediate size gains. This is normal adaptation, not failure. Ensure you are recovering adequately, as this turnover process is energy-intensive.

Successful long-term weight loss maintenance does not require a single uniform strategy; individuals can maintain weight loss with either high physical activity or low physical activity, provided they employ compensatory dietary and behavioral strategies appropriate to their activity level.

You do not need to become a marathon runner to keep weight off. If you are a 'low exerciser,' focus on dietary strategies like portion control and food choices. If you are a 'high exerciser,' you may need to combine significant activity with stricter dietary adherence (e.g., lower fat, higher restraint). Find the strategy mix that works for your lifestyle and biology; there is no single correct way to maintain weight loss.

GLP-1 receptor agonists for obesity treatment cause significant loss of lean body mass (approximately 38% of total weight loss) and muscle mass, increasing the risk of sarcopenia and bone loss, particularly in the absence of structured resistance training and adequate protein intake.

If you are taking a GLP-1 medication for weight loss, expect to lose some muscle along with fat. To protect your strength and metabolism, you must prioritize resistance training (weight lifting or bodyweight exercises) and ensure you are eating enough protein. Without these steps, you risk losing significant muscle mass, which can happen with any rapid weight loss method.

Short-term muscle disuse atrophy (4 days) in humans is driven by declines in muscle protein synthesis (MPS), not by increased muscle protein breakdown (MPB).

If you are immobilized or inactive for a few days, your muscle loss is caused by a drop in your body's ability to build new muscle protein, not by an increase in muscle destruction. To mitigate this, interventions should focus on stimulating muscle protein synthesis (e.g., through protein intake or resistance stimuli if possible) rather than just trying to block breakdown pathways.

Ingesting carbohydrate during 60 minutes of submaximal running or cycling increases plasma glucose oxidation but does not reduce (spare) mixed muscle glycogen utilization compared to water ingestion.

If you are exercising for about an hour at a moderate intensity (where you can speak in short sentences), drinking a carbohydrate solution will increase the amount of sugar your blood burns for energy. However, it will NOT save your muscle glycogen stores compared to drinking water. You should still consume carbohydrates to maintain blood glucose levels, but do not expect it to extend your endurance by saving muscle fuel during this specific duration and intensity.

Lean body mass is preserved on average in both TRF and MBD groups, but individual responses vary significantly, with some participants losing lean mass despite adequate protein intake.

While your group average lean mass stays stable, individual results vary. Ensure you are lifting weights and eating enough protein (1.4-2.0g/kg body weight or 2.3-3.1g/kg lean mass) to maximize the chance of preserving muscle while losing fat.

In individuals with type 2 diabetes, a history of cardiovascular disease and higher baseline BMI are associated with modestly poorer cognitive function following an intensive lifestyle intervention compared to standard care.

For individuals with type 2 diabetes who are obese or have a history of cardiovascular disease, intensive lifestyle interventions may not improve cognitive function and could be associated with modestly poorer outcomes compared to standard care. These individuals should discuss potential risks and benefits with their healthcare provider.

High consumption of sugar-sweetened beverages (SSBs) amplifies the genetic predisposition to higher body mass index (BMI), such that individuals with high genetic risk scores experience significantly greater weight gain from SSB intake than those with low genetic risk.

If you have a family history of obesity, your sensitivity to sugary drinks is likely higher than average. Reducing or eliminating sugar-sweetened beverages can significantly reduce your genetic risk of gaining weight, even if you have a high genetic predisposition.

Higher trunk adiposity is significantly associated with an increased risk of having two or more cardiometabolic risk factors (high blood pressure, low HDL, high triglycerides, high glucose) in both white and African American adults, whereas higher leg adiposity is associated with a decreased risk in these populations.

Focus on body composition distribution, not just total weight. High trunk fat (belly area) is a strong predictor of metabolic issues, while higher leg fat appears protective. While you cannot easily choose where to lose fat, understanding that trunk adiposity is the primary driver of risk highlights the importance of visceral fat reduction strategies over simple caloric restriction if leg mass is preserved.

In older adults (aged 65-100), central adiposity measures (specifically waist/hip ratio) and midlife BMI are significant independent predictors of coronary heart disease risk, whereas general adiposity (baseline BMI) loses significance after adjusting for mediators.

For adults over 65, tracking waist circumference and hip circumference (to calculate waist/hip ratio) and recalling body mass index at age 50 provides a more accurate assessment of coronary heart disease risk than current body weight or BMI alone. If you have a higher waist-to-hip ratio or were overweight in midlife, your risk remains elevated even if your current BMI is normal.

In older women, waist/hip ratio is a significant independent predictor of ischemic stroke risk, whereas in older men, only baseline BMI (≥30 kg/m²) is a significant predictor of ischemic stroke risk.

For older adults, stroke risk assessment should be sex-specific. Women should prioritize monitoring their waist-to-hip ratio, as it is a stronger predictor of stroke than BMI. Men should focus on maintaining a BMI below 30 kg/m², as this is the most significant predictor of stroke risk in this demographic.

Higher circulating levels of the trans-fatty acid isomer trans/trans-18:2 (t/t-18:2) are associated with significantly increased risks of total mortality, cardiovascular disease (CVD) mortality, and total coronary heart disease (CHD).

Avoid foods containing partially hydrogenated oils, as they are the primary source of the trans fatty acid isomer t/t-18:2, which is linked to higher risks of heart disease and death. While natural sources of trans fats exist (like in some dairy/meat), this study highlights that the industrial isomer t/t-18:2 is the most harmful. For older adults, minimizing industrial trans fats is a key step for longevity.

Person-specific characteristics (genetic, hormonal, psychosocial, and behavioral) significantly predict individual variability in weight loss response to obesity interventions, making precision medicine strategies potentially more effective than broad application of treatments.

Stop assuming a single diet or exercise plan works for everyone. Your body's unique genetics, hormones, and psychology dictate how you respond to treatment. Instead of blindly following a generic plan, look for early signs of response (like weight loss in the first few weeks) to decide whether to continue or switch strategies. If you have specific genetic conditions (like leptin deficiency), targeted medical therapies may be available, but for most, success depends on matching the intervention to your specific biological and psychological profile.

Replacing saturated fatty acids (SFA) from dairy foods with polyunsaturated fatty acids (PUFA) reduces LDL cholesterol but does not consistently reduce cardiovascular disease (CVD) risk or mortality, suggesting that LDL-C reduction alone is not a reliable predictor of CVD outcomes when the source is dairy.

Current guidelines suggest limiting saturated fats to reduce heart disease risk. However, this review indicates that replacing dairy saturated fats with polyunsaturated fats lowers LDL cholesterol but does not necessarily lower your actual risk of heart attacks or death. This suggests that simply counting saturated fat grams may be less important than the overall food matrix (e.g., eating whole dairy products) and other lipid markers like the LDL particle size.

High intake of saturated fatty acids from dairy foods is associated with neutral or negative (protective) associations with cardiovascular disease risk, unlike SFAs from other sources which may increase risk.

You do not need to restrict dairy foods to manage heart health risk. While general guidelines limit saturated fats, evidence suggests that the specific fats found in dairy (like C15:0 and C17:0) are associated with neutral or even protective effects on cardiovascular disease, unlike saturated fats from other sources.

Behavioral weight management programs (BWMPs) produce sustained improvements in cardiometabolic risk factors (blood pressure, lipid profile, glycemic control) for at least 5 years after program end, despite significant weight regain.

If you participate in a structured weight loss program, expect your blood pressure, cholesterol, and blood sugar to improve significantly. Even if you regain some weight after the program ends, these health benefits will likely persist for at least five years. Do not be discouraged by partial weight regain; the metabolic improvements are durable.

Adipocyte and preadipocyte formation rates in subcutaneous abdominal fat positively correlate with overall percent body fat in women.

As women gain more body fat, their abdominal fat cells tend to turn over and expand more actively. This suggests that higher body fat levels drive increased cellular activity in the belly area, which may contribute to the metabolic risks associated with abdominal obesity.

Short-term consumption of fast-food meals (a subset of UPFs) increases bile-tolerant bacteria (Collinsella, Parabacteroides, Bilophila) and decreases fiber-fermenting bacteria (Lachnospiraceae, Butyricicoccus).

Eating fast food for just 4 days can shift your gut bacteria, increasing bile-tolerant types and decreasing fiber-fermenting types. To maintain a healthy microbiome, limit fast food frequency and prioritize fiber-rich foods.

The statistical method used to analyze the relationship between muscle hypertrophy and strength gain significantly alters the observed correlation, with hierarchical linear modeling (HLM) revealing stronger within-individual associations than between-subject correlations or ANCOVA.

If you are designing a study or interpreting research on muscle growth and strength, do not rely on simple between-subject correlations (comparing Person A to Person B). Use within-subject analyses (like Hierarchical Linear Modeling) to see how an individual's growth relates to their strength gain. For practitioners, this means individual responses vary wildly; some people get strong without growing much, and some grow without getting proportionally stronger. Do not assume muscle size is the sole driver of strength.

Caloric restriction-induced weight loss in nonobese younger adults causes a significant decline in bone mineral density (BMD) at the spine and proximal femur, characterized by increased bone resorption and decreased bone formation.

If you are a younger, normal-weight individual planning to lose weight through caloric restriction, be aware that your bone density may decrease by about 2% over two years. This is likely a normal adaptation to your new, lighter body weight rather than a sign of disease. To mitigate this, ensure you are getting adequate calcium and vitamin D, and consider incorporating weight-bearing or muscle-loading exercises, which have been shown to attenuate bone loss during dieting.

High maximal fat oxidation (MFO) is associated with successful long-term weight loss maintenance, but the underlying mechanism differs from that in individuals who regain weight despite having similarly high MFO.

If you are trying to maintain weight loss, simply having a high capacity to burn fat isn't enough if your body is overloaded with lipids. Successful maintainers typically have higher cardiovascular fitness (V˙ O2max) and better muscle lipid handling proteins (CD36, FABPpm) compared to those who regain weight, who may have high fat oxidation simply because they have more fat available to burn. Focus on building fitness and muscle health rather than just chasing fat oxidation numbers.

Prevention and reversal of the transition from metabolically healthy obesity (MHO) to metabolically unhealthy obesity (MUO) requires multifaceted interventions targeting both adipose tissue intrinsic factors (e.g., promoting adipogenesis) and extrinsic drivers (e.g., hyperinsulinemia, circadian disruption), with lifestyle changes serving as the foundation but often requiring pharmacological or surgical augmentation for substantial weight loss and metabolic correction.

If you have obesity but normal metabolic markers (MHO), do not assume you are safe. Approximately half of people in this category will develop metabolic complications (MUO) over time. Focus on lifestyle changes (diet, exercise) to maintain metabolic health. If lifestyle changes are insufficient to prevent progression, consult a healthcare provider about pharmacological or surgical options to address underlying drivers like hyperinsulinemia or adipose dysfunction.